Projects
The pharmaceutical projects listed in this section are those that are announced from time to time around the world
Cellares Secures $255M Series to Launch Innovative IDMO and Smart Factory for Life-Saving Cell Therapies
Cellares, an industry leader in Integrated Development and Manufacturing Organizations IDMO focused on cell therapy, is positioned to address the increasing global demand for cell therapies with its ambitious global Smart Factory expansion plans
Merck to Inject €23 Million into Kansas, USA Facility for Cell Culture Media Production Expansion
Merck Designates Lenexa, Kansas Facility as North Americas Largest Dry Powder Cell Culture Media Site and Center of Excellence
Upperton to Construct a £15m Development and GMP Manufacturing Facility in Nottingham
The facility will include ten GMP manufacturing suites, quality control laboratories, and formulation development capabilities with a pilot plant
Enzene Biosciences to Expand into New Jersey, Investing $50 Million in Bio Manufacturing Plant
Enzene Biosciences, a global biotech company headquartered in India, has announced plans to establish its first manufacturing plant in New Jersey
Croda Initiates Construction of Advanced Pharmaceutical Excipients Manufacturing Facility in Pennsylvani
Croda, Inc Breaks Ground on Lamar, PA Facility for Innovative Pharmaceutical Excipients Manufacturing, Enhancing Lives with Smart Science
EUROAPI Announces €50 Million Investment in Budapest Site to Meet Increasing Prostaglandin Demand
EUROAPI, a pharmaceutical company has revealed its plans to invest 50 million in constructing a stateoftheart production plant at its Budapest site This significant investment is aimed at expanding
Colorcon, Inc. Expands Operations with a New Film Coating Manufacturing Facility in Malaysia
Colorcon, Inc is delighted to announce its recent investment in a stateoftheart manufacturing plant in Johor State, Malaysia
Aurigene Pharmaceutical Services announces plans for biologics CDMO capacity expansion through new biomanufacturing facility
Aurigene Pharmaceutical Services invests $40 million USD in an RD and pilot scale facility, while also securing exclusive access to largescale GMP commercial manufacturing capacity, including fillfinish capabilities
Meissner to Build New US$250 million Manufacturing Facility in USA
Meissner Corporation has recently announced its investment of US$250 million in the construction of a new manufacturing facility in AthensClarke County, Georgia, USA
Catalent Initiates Construction of US$20 million Clinical Supply Facility in Germany
Catalent has initiated the construction of a new clinical supply facility in Schorndorf, Germany, with an investment of US$20 million
